Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion

Amit Ringel; Ronit Elhasid; Shlomi Constantini; Jonathan Roth; Rina Dvir

doi:10.1002/pbc.30312

Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion

Amit Ringel^*, Ronit Elhasid, Shlomi Constantini, Jonathan Roth, Rina Dvir

^*Corresponding author for this work

Tel Aviv Sourasky Medical Center

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Article number	e30312
Journal	Pediatric Blood and Cancer
Volume	70
Issue number	7
DOIs	https://doi.org/10.1002/pbc.30312
State	Published - Jul 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pbc.30312

Cite this

@article{1100b5252531424a8266d480e17f3d7a,

title = "Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion",

author = "Amit Ringel and Ronit Elhasid and Shlomi Constantini and Jonathan Roth and Rina Dvir",

year = "2023",

month = jul,

doi = "10.1002/pbc.30312",

language = "אנגלית",

volume = "70",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion

AU - Ringel, Amit

AU - Elhasid, Ronit

AU - Constantini, Shlomi

AU - Roth, Jonathan

AU - Dvir, Rina

PY - 2023/7

Y1 - 2023/7

UR - http://www.scopus.com/inward/record.url?scp=85150982816&partnerID=8YFLogxK

U2 - 10.1002/pbc.30312

DO - 10.1002/pbc.30312

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 36965191

AN - SCOPUS:85150982816

SN - 1545-5009

VL - 70

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 7

M1 - e30312

ER -

Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion

UN SDGs

Access to Document

Other files and links

Cite this